Evidence map›Paper›PMID 35570828›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2022

Validation, kinetic modeling, and test-retest reproducibility of [

Daniele Bertoglio, Franziska Zajicek, Stef De Lombaerde, Alan Miranda, Sigrid Stroobants, Yuchuan Wang, Celia Dominguez, Ignacio Munoz-Sanjuan, Jonathan Bard, Longbin Liu and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. SV2A PET Imaging Detects Severity-Dependent Synaptic Changes After Experimental Traumatic Spinal Cord Injury.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  5. Article
  6. SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Preclinical evaluation of [Journal of molecular medicine (Berlin, Germany) · 2025
    Article
  8. Article
  9. Article
  10. Assessing non-invasive quantitative methods for [European journal of nuclear medicine and molecular imaging · 2025
    Article
  11. Article
  12. Article
  13. Observational
  14. Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  15. Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Review
  16. [Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  17. Resting-State Functional MRI and PET Imaging as Noninvasive Tools to Study (Ab)Normal Neurodevelopment in Humans and Rodents.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Review
  18. Article
  19. Isoflurane and ketamine-xylazine modify pharmacokinetics of [Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Daniele BertoglioMolecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp, Belgium.ORCID 0000-0003-4205-5432
Franziska ZajicekMolecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp, Belgium.
Stef De LombaerdeMolecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp, Belgium.
Alan MirandaMolecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp, Belgium.ORCID 0000-0002-5381-015X
Sigrid StroobantsMolecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp, Belgium.
Yuchuan WangCHDI Management/CHDI Foundation, Los Angeles, California, USA.
Celia DominguezCHDI Management/CHDI Foundation, Los Angeles, California, USA.
Ignacio Munoz-SanjuanCHDI Management/CHDI Foundation, Los Angeles, California, USA.
Jonathan BardCHDI Management/CHDI Foundation, Los Angeles, California, USA.
Longbin LiuCHDI Management/CHDI Foundation, Los Angeles, California, USA.
Jeroen VerhaegheMolecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp, Belgium.
Steven StaelensMolecular Imaging Center Antwerp (MICA), University of Antwerp, Antwerp, Belgium.
University of Antwerp · BECHDI Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alterations in synaptic vesicle glycoprotein 2 A (SV2A) have been associated with several neuropsychiatric and neurodegenerative disorders. Therefore, SV2A positron emission tomography (PET) imaging may provide a unique tool to investigate synaptic density dynamics during disease progression and after therapeutic intervention. This study aims to extensively characterize the novel radioligand [

Indexed as

BrainSynaptic VesiclesAnimalsGlycoproteinsLevetiracetamMicePositron-Emission TomographyRadiopharmaceuticalsReproducibility of ResultsGlycoproteinsLevetiracetamRadiopharmaceuticals[18F]SynVesT-1kinetic modelingMouseSV2Asynapse density

Identifiers

PMID35570828
PMCPMC9536120
OpenAlexW4280544176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.